Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or
Patents for C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
06/2010
06/24/2010WO2010070060A1 Bicyclic pyrazoles as protein kinase inhibitors
06/24/2010US20100160163 Fused heterocyclic sulfonylurea compound, herbicide containing the same, and method for controlling weed with the same
06/24/2010CA2747715A1 Thiazolopyridine sirtuin modulating compounds
06/24/2010CA2747427A1 Method for producing diamine derivative
06/24/2010CA2746077A1 Fused imidazole carboxamides as trpv3 modulators
06/24/2010CA2745459A1 Thiazoles as cannabinoid receptor ligands
06/23/2010EP2199295A1 Compounds with 7-member cycle and the pharmaceutical use thereof for preventing and treating diabetes and metabolism syndrome
06/23/2010EP2197552A2 Novel tetrahydrofusedpyridines as histone deacetylase inhibitors
06/23/2010EP1711505B1 Process for the preparation of thiazolopyrimidines
06/23/2010CN101754970A Macrocyclic indole derivatives for the treatment of hepatitis c infections
06/23/2010CN101747350A thiazolothiazole derivative
06/22/2010US7741349 Neuroprotectants; treatment of neuropathies resulting from chemtherapeutic agents used in the treatment of HIV and proliferative disease such as cancer and treatment of inflammatory diseases; neurodegenerative diseases; enzyme inhibitors for seine/threonine kinases, phosphatases; Alzheimer'
06/22/2010US7741336 N-(1-Methyl-1-phenyl-ethyl)-3-{[2-(2-oxo-2,3-dihydro-1H-indol-5-ylamino)-5-trifluoromethyl-pyrimidin-4-ylamino]-methyl}-benzenesulfonamide, useful in the treatment of breast cancer
06/22/2010US7741332 Brain and nervous system disorders such as mood disorders or urinary incontinence, pain, anxiety, hearing loss; 2-(carbonylamino)-1,1-dioxo-1H-benzo[1,2,4]thiadiazines, 4-(oxo or thiooxo)-3-(carbonylamino)-quinazolines, and 1-(oxo or thiooxo)-2-(carbonylamino)-1,2-dihydroisoquinolines
06/22/2010US7741325 Benzo[b]chromeno-naphthyridin-7-one and pyrano[2′,3′:7,8]quino[2,3-b]quinoxalin-7-one compounds
06/17/2010US20100152208 Bicyclic heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
06/17/2010US20100152192 Fused imidazole carboxamides as trpv3 modulators
06/17/2010US20100150913 Organic compounds
06/17/2010US20100150866 Hepatitis C Virus Inhibitors
06/17/2010US20100150833 Compounds and amyloid probes thereof for therapeutic and imaging uses
06/16/2010EP1784409B1 Substituted thienopyrrole carboxylic acid amides, pyrrolothiazole carboxylic acid amides, and related analogs as inhibitors of casein kinase i epsilon
06/16/2010EP1735302B1 4-amino-piperidine derivatives as monoamine uptake inhibitors
06/16/2010CN1894258B Compositions useful as inhibitors of protein kinases
06/15/2010US7737159 such as 2-(3-(aminomethyl)pyrrolidin-1-yl)-4-(4-methoxybenzyl)-7-oxo-4,7-dihydro[1,3]thiazolo[4,5-b]pyridine-6-carboxylic acid, used for treating drug-resistant bacterial infections
06/15/2010US7737145 Diamine derivatives as inhibitors of leukotriene A4 hydrolase
06/15/2010US7737136 high affinity agonists; high specificity; side effect reduction; endometriosis; hormone dependent cancers, fertility control; dibenzo[b,f]pyrido[1,2-d][1,4] oxazepin, dibenzo[b,f]pyrido[1,2-d][1,4]thiazepim, dibenzo[b,f]pyrido[1,2-d][1,4]diazepin and dibenzo[c,f]pyrido[1,2-a]azepine derivatives
06/15/2010US7737134 pateamine A analogs, having antiproliferative effects in vivo and in vitro by a novel drug mechanism of action, including inhibition of eukaryotic initiation factor-4A (eIF4A)-dependent translation initiation, causing cell cycle arrest or inducing apoptosis in transformed cells; treatment of leukemia
06/15/2010CA2529686C 2-acylaminothiazole derivative or salt thereof
06/15/2010CA2518224C Novel isothiazolopyrimidinones and isoxazolopyrimidinones and uses thereof
06/10/2010WO2010065893A1 Raf inhibitors and their uses
06/10/2010WO2010065721A1 Stem cell cultures
06/10/2010WO2010064611A1 Heterocyclic compound and use thereof
06/10/2010WO2010064020A1 Imidazopyridine compounds
06/10/2010US20100145048 Compounds for the treatment of inflammatory disorders
06/10/2010US20100145041 Thiazolyl-dihydro-quinazoline compounds and processes for preparing same
06/10/2010US20100144778 Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment
06/10/2010US20100144735 Substituted piperidino phenyloxazolidinones having antimicrobial activity with improved in vivo efficacy
06/10/2010US20100144717 2-quinolinone and 2-quinoxalinone-derivatives and their use as antibacterial agents
06/10/2010US20100144712 Triazole derivatives having antifungal activity, method for the preparation thereof, and pharmaceutical composition comprising the same
06/10/2010US20100143499 Dimeric iap inhibitors
06/10/2010US20100143253 Compounds and amyloid probes thereof for therapeutic and imaging uses
06/10/2010CA2745266A1 Stem cell cultures
06/10/2010CA2744713A1 Raf inhibitors and their uses
06/09/2010EP2193133A2 Imidazolothiadiazoles for use as protein kinase inhibitors
06/09/2010EP1268488B1 A process for preparing cephalosporin derivatives using new thiazole compound
06/09/2010CN1852712B Dual NK1/NK3 antagonists for treating schizophrenia
06/09/2010CN1791585B Cyclic sulfonamides for inhibition of gamma-secretase
06/09/2010CN1780835B Novel fused heterocycles and uses thereof
06/09/2010CN101730696A 3-aza-bicyclo[3.3.0]octane compounds
06/08/2010US7732608 Clopidogrel p-toluenesulfonate (or Clopidogrel tosylate), Clopidogrel benzenesulfonate (or Clopidogrel besylate) and Clopidogrel methanesulfonate (or Clopidogrel mesylate); antianginal agent, antiplatelet agent; decreases morbid events in people with established atherosclerotic disease
06/08/2010US7732507 Spirotetrathiocarbamates and spirooxothiocarbamates
06/08/2010US7732468 3-aryl-6-aryl-[ 1,2,4]triazolo[3,4-b][1,3,4]thiadiazoles and related compounds as activators of caspases and inducers of apoptosis and the use thereof
06/08/2010US7732186 Recombinant methods and materials for producing epothilone and epothilone derivatives
06/03/2010WO2010062038A2 Tyrosine kinase inhibitor compound, isomer thereof or pharmaceutically allowable salt thereof, and pharmaceutical composition containing the same
06/03/2010US20100137611 Thiazolothiazole derivative
06/03/2010US20100137303 New compound 255
06/03/2010US20100137302 Fused Thiazole Derivatives as Kinase Inhibitors
06/03/2010US20100137299 Spiro-oxindole compounds and their use as therapeutic agents
06/03/2010US20100137288 Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof
06/03/2010US20100137282 Tricyclic nitrogen containing compounds as antibacterial agents
06/02/2010EP2190845A2 Hdac inhibitors
06/02/2010EP2190449A1 Macrocyclic compounds and methods of treatment
06/02/2010CN101220044B Telomerase inhibitor, preparation method and application thereof
06/01/2010US7728017 1,2,4-triazolo[3,4-b][1,3,4]thiadiazole derivatives, useful as tyrosine kinase inhibitors for treating or lessening the severity of proliferative disorders
06/01/2010US7727979 Guanidine derivatives and their use as neuropeptide FF receptor antagonists
06/01/2010CA2515841C Novel 2-pyridine carboxamide derivatives
06/01/2010CA2438547C Isoxazoline derivative and herbicide containing the same as the active ingredient
06/01/2010CA2409827C Arylmethylamine derivatives for use as tryptase inhibitors
05/2010
05/27/2010WO2010059668A1 A triazolothiadiazole inhibitor of c-met protein kinase
05/27/2010WO2010058751A1 Pharmacologically acceptable salt of [1,3,4]oxadiazole compound or hydrate thereof
05/27/2010WO2009140624A3 Glucokinase activators
05/27/2010CA2743000A1 A triazolothiadiazole inhibitor of c-met protein kinase
05/26/2010EP2188282A2 1,2-diamido-ethylene derivatives as orexin antagonists
05/26/2010EP2188271A2 Heterocyclic compounds and uses as anticancer agents
05/26/2010EP2188255A1 Heterocyclic amides useful for the treatment of cancer and psoriasis
05/26/2010CN1835948B 2-acylaminothiazole derivative or its salt
05/26/2010CN1713907B N-substituted pyrrolidin derivatives as dipeptidyl peptidase IV inhibitors
05/26/2010CN1649883B Bicyclic 6-alkylidene-penems as lactamases inhibitors
05/26/2010CN101712657A heteroarylcarbamoylbenzene derivative
05/26/2010CN101711763A Prulifloxacin composition and preparation method thereof, and synthesis method of raw material drugs
05/25/2010US7723366 Cardiovascular disorders; antidiabetic agents; anticancer agents
05/25/2010CA2470476C Pyrrolidine and piperidine derivates as nk1 antagonists
05/20/2010WO2010056875A1 Pyridazinones and their use as btk inhibitors
05/20/2010WO2010055348A1 [4- (1-amino-ethyl) -cyclohexyl] -methyl-amines as antibacterials
05/20/2010WO2010013078A8 Pyrrolidinyl-alkyl-amide derivatives their preparation and their therapeutic application as ccr3 receptor ligands
05/20/2010CA2742520A1 [4- (1-amino-ethyl) -cyclohexyl] -methyl-amines as antibacterials
05/19/2010EP2185512A2 Trans-3-aza-bicyclo[3.1.0]hexane derivatives
05/19/2010CN101711253A Novel compounds as cannabinoid receptor ligands
05/18/2010US7718669 Triazolopyridine derivatives as inhibitors of lipases and phospholipases
05/18/2010US7718651 Inhibiting polymerization of FtsZ in a bacterium by contactng with 2,3-diphenyl-6-(ethoxycarbonylamino)-8-(4-(diethylamino)-1-methylbutylamino)pyrido[2,3-b]pyrazine, optionally linked to a permeability enhancer to allow the compound to cross the bacterium's cell envelope
05/18/2010CA2422371C Pyrazole compounds useful as protein kinase inhibitors
05/18/2010CA2422367C Pyrazole compounds useful as protein kinase inhibitors
05/18/2010CA2131797C Condensed indole derivatives as 5ht4-receptor antagonists
05/14/2010WO2010054067A1 Gamma secretase modulators
05/14/2010WO2010054058A1 Imidazolothiazole compounds as modulators of protein kinase
05/14/2010WO2010054024A2 Novel compounds as cannabinoid receptor ligands
05/14/2010WO2010017093A3 Dopamine receptor ligands with enhanced duration of action
05/14/2010WO2009097515A3 [a]-fused indole compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses
05/14/2010CA2742602A1 Gamma secretase modulators
05/14/2010CA2741047A1 Novel compounds as cannabinoid receptor ligands
1 ... 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 ... 152